As COVID19 evolved into a world-wide pandemic, there seemed to be an inexplicable decline in stroke presentations both in the US and abroad.[@bib0001] Then within weeks, some of the hardest hit hospitals began to report more strokes, particularly in young patients with no apparent risks.[@bib0002] In light of these reports, we reviewed our stroke program data to determine if similar or other novel patterns were present in our patient population.

Results {#sec0001}
=======

Our hospital is a Thrombectomy Stroke Center (TSC) in south Florida whose county ranked second in COVID 19 cases and deaths. There was a profound drop in ED (emergency department) visits from 2,349 in the first two weeks of March to 1,178 in the final two weeks of April. Stroke alerts dropped from 34 to 14 during the same period ([Table 1](#tbl0001){ref-type="table"} ). The total number of patients admitted with an acute stroke in March and April of 2020 was 46, compared to 68 in 2019. There were only seven stroke neurointervention cases during the same period compared to 14 in 2019.Table 1Decline in Patient Presentations in Early Covid-19 PandemicTable 1DATEEMERGENCY ROOM VISITSSTROKE ALERTS"Walk-in" ArrivalsEMS ArrivalsMARCH  Week 1 & 22,02432534  Week 3 & 41,44626721APRIL  Week 1 & 21,0741779  Week 3 & 499018814

Despite these declines, we had 12 tissue plasminogen activator (tPA) eligible patients in March 2020, and typically we average six/month. There were significantly more patients ≤ 60 years of age who underwent any acute stroke intervention (tPA and/or neurointervention). In March, 5 of 12 were ≤ 60 years of age, compared to only two of 13 in 2019 ([Graph 1](#fig0001){ref-type="fig"} ). Amongst the thrombectomy cases, two were very young, 31 and 35 years old and both were African American.Graph 1Age of patients eligible for acute stroke interventions in 2020 compared to 2019.Graph 1

Discussion {#sec0002}
==========

Our TSC\'s ED visits, stroke alerts, stroke admissions and neurointervention cases did indeed drop precipitously in the first few months of the Covid-19 pandemic in keeping with some of the earliest reports. But in spite of these dramatic declines, we had twice the number of patients who were tPA-eligible in March, the month that coincided with our region\'s onset of coronavirus presentations. Whether directly related to coronavirus infection is difficult to prove as testing was not yet widespread and other risk factors that may have been exacerbated by the pandemic such as medication non-compliance, lifestyle changes or difficulty accessing health care, cannot be excluded. Nonetheless, as the thromboembolic risks associated with Covid-19 infection become increasingly apparent,[@bib0003] ^,^ [@bib0004] the brief uptick in tPA cases we saw may have been a "red flag" and a unique pattern to remember as we face the coming months of possible viral surges. Another concern was raised by noting the overall lower stroke admissions to the hospital. Were only the patients with more severe or obvious deficits coming to the ED? Were people with mild symptoms simply avoiding the hospital giving the false impression of an overall lower stroke incidence? The answer remains unclear however our center has instituted community stroke education to remind people of the benefit of early intervention and we remain vigilant to look for "missed strokes" so that proper secondary prevention can be instituted.

Similar to the earlier reports from New York and Philadelphia, our center also encountered younger patients with large vessel occlusions. Although the neurointervention caseload was uncharacteristically low in March and April, four of the seven patients were ≤ 60 years old, and two of those were African American women in their 30's. This trend of younger stroke patients was also present in the candidates for tPA. This was a novel finding and quite unexpected at our TSC, as our surrounding community is predominantly Caucasian with 34% of the population ≥ 65 years of age, no recent changes in the catchment area, physician staffing or proximity of other stroke centers that might have affected our hospital\'s population.

In conclusion, our findings support the notion that Covid-19 has surely impacted stroke presentations, even in presumed low risk communities such as ours, and physicians caring for acute stroke patients may need to recognize and anticipate these unique patterns. As we move forward in this pandemic, it will also be imperative that we determine what mechanisms underlie these changes so that we can implement both preventative strategies and continue the most effective acute stroke treatments.
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